maximize
infection protection
Tyuoz treats intra-abdominal infections with 97% success. Also treats pediatric pneumonia and surgical wound infections. It is a favorable treatment for pelvic infections in women. Best for severe nosocomial infections.
An extended-spectrum
Antibiotic
Tyuoz has a 97% success rate in treating intra-abdominal infections and is also effective against pediatric pneumonia and surgical wound infections. It is a preferred treatment for pelvic infections in women and is considered the best option for severe nosocomial infections.
- For intra-abdominal infections, there is a 97% success rate in treating the bacteria causing the infection. (1)
- It is highly effective for treating pneumonia in children with respiratory tract infections. (2)
- As a single therapy, it is a good option for treating surgical wound infections. (3)
- It has been shown to penetrate female genital tract tissues well, making it a favorable treatment for pelvic infections in women. (4)
- When it comes to infections acquired in hospitals, it is the best combination for treating severe cases. (5)
1.Asian J Surg 2004 Jul; 27(3):227-35 | 2. Dept of otolaryngology, 2004 | 3. Chemotherapy 2006; 52(1): 43-5 | 4. Inf. dis. in obs. & gyn. (1994), issue 1, pg 20-24 | 5. Journal of infection & chemotherapy, august 2007
For ultimate protection
against infections
- Highly effective for pediatric pneumonia
- Good for surgical wound infections
- Best for severe nosocomial infections
